Cures & Capital

Episode 9 - Reflections and Takeaways

Martin Slezak and Simon Birksø

Over the past few months, we’ve had the chance to speak with some of the sharpest minds in the industry—thinkers and practitioners who have shaped how we understand drug innovation, R&D productivity, portfolio strategy, and other critical topics.

In this episode, we bring together the major insights and lessons, highlighting patterns that emerged across the different conversations.

We also spotlight the unique takeaways from each guest to help ensure these key learnings really stick. Whether you're an R&D leader, investor, innovator, or strategist, these insights will help you rethink how to create real, lasting value in an industry undergoing rapid change.

If you want to connect with us - we would love to hear from you:
Linkedin: https://www.linkedin.com/company/cures-capital-podcast

If you prefer to get the episodes as just audio, you can also get the podcast from Spotify and Apple Podcasts.

Disclaimer: This podcast and activities related to it are completely independent from our day jobs. All the views and opinions expressed through this channel are solely our own and do not represent or in any way reflect the views and opinions of the companies we work for.

People on this episode